[IPO Subscription] KNS Inc. Closes Day 2... Proportional Competition Rate at 2,159.1:1, Subscription Deposits Exceed 3 Trillion Won
The two-day IPO subscription schedule for KNS Inc. concluded on the afternoon of the 5th. This subscription, conducted over the 4th and 5th with IBK Investment
![[IPO Subscription] KNS Inc. Closes Day 2... Proportional Competition Rate at 2,159.1:1, Subscription Deposits Exceed 3 Trillion Won](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F580134%2F631acbbd8afdeca6%2Foriginal.webp&w=1920&q=75)
The two-day IPO subscription schedule for KNS Inc. concluded on the afternoon of the 5th. This subscription, conducted over the 4th and 5th with IBK Investment & Securities as the lead underwriter, received a total of 73,347 applications.
The subscription recorded a fierce proportional competition rate of 2,159.1:1. Subscription deposits flooded in, surpassing 3 trillion won, demonstrating overwhelming investor interest. The equal allocation shares stood at 4.09, meaning subscribers were estimated to receive anywhere from 4 to 5 shares.
Accordingly, investor attention is now focused on KNS Inc.'s first-day stock price performance as the company is set to be listed on the 13th.
Meanwhile, according to regulatory filings, KNS Inc., founded in 2001, is a specialized manufacturer of satellite communication antennas for maritime and military use. The company develops, manufactures, and sells satellite communication antennas designed for specialized environments where the use of terrestrial communication networks is limited or highly reliable communications are required, such as on surface ships and submarines.
[※ This article is provided as reference material for investment decisions and does not constitute a recommendation to buy or sell any specific stock. The final responsibility for investment decisions lies with the investor.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] HLB to Issue Private CB to Raise KRW 30 Billion for New Drug Development and Commercialization](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F580558%2Fe71c71593626b654%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Breaking] Woori Technology Issues KRW 40 Billion Zero-Interest Convertible Bonds to Raise Funds for Nuclear Power and New Businesses](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F08%2F594282%2Fa11e3219b605116c%2Fvariants%2Fhero.webp&w=1920&q=75)

![[Breaking News] Samcheondang Pharmaceutical Corrects European Oral Insulin Clinical Trial Disclosure... "16 Subjects, Total Dosing Marked as 64"](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581748%2Fed2a73c31f2e2200%2Fvariants%2Fhero.webp&w=1920&q=75)